{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:43:16Z","timestamp":1792597396080,"version":"4.5.0"},"reference-count":18,"publisher":"MyJove Corporation","issue":"221","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/68466","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T18:02:30Z","timestamp":1753984950000},"source":"Crossref","is-referenced-by-count":0,"title":["<em>Ookluc<\/em>: A <em>Plasmodium berghei<\/em> Line for Identifying Transmission-blocking Compounds"],"prefix":"10.3791","author":[{"given":"Jana\u00edna T.","family":"Novais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Calit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia G.","family":"Morosini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor A.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo F.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiomara A.","family":"Gait\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Y.","family":"Bargieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"ref1","volume-title":"World malaria report 2024: addressing inequity in the global malaria response","year":"2025","unstructured":"World Health Organization. World malaria report 2024: addressing inequity in the global malaria response. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2024 (2025)."},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","type":"journal-article","article-title":"Malaria biology and disease pathogenesis: insights for new treatments","volume":"19","author":"Miller","year":"2013","unstructured":"Miller, L. H., Ackerman, H. C., Su, X., Wellems, T. E. Malaria biology and disease pathogenesis: insights for new treatments. Nature Med. 19 (2), 156-167 (2013).","journal-title":"Nature Med"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/vaccines11091452","type":"journal-article","article-title":"Malaria Vaccines: From the Past towards the mRNA Vaccine Era","volume":"11","author":"Tsoumani","year":"2023","unstructured":"Tsoumani, M. E., Voyiatzaki, C., Efstathiou, A. Malaria Vaccines: From the Past towards the mRNA Vaccine Era. Vaccines. 11 (9), 1452 (2023).","journal-title":"Vaccines"},{"issue":"10","key":"ref4","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrmicro3111","type":"journal-article","article-title":"Looking under the skin: the first steps in malarial infection and immunity","volume":"11","author":"M\u00e9nard","year":"2013","unstructured":"M\u00e9nard, R. et al. Looking under the skin: the first steps in malarial infection and immunity. Nature Rev. Microbiol. 11 (10), 701-712 (2013).","journal-title":"Nature Rev. Microbiol"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.3390\/ph17070962","type":"journal-article","article-title":"Transmission-blocking strategies for malaria eradication: Recent advances in small-molecule drug development","volume":"17","author":"Appetecchia","year":"2024","unstructured":"Appetecchia, F. et al. Transmission-blocking strategies for malaria eradication: Recent advances in small-molecule drug development. Pharmaceuticals. 17 (7), 962 (2024).","journal-title":"Pharmaceuticals"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.01144-06","type":"journal-article","article-title":"High-throughput Plasmodium falciparum growth assay for malaria drug discovery","volume":"51","author":"Baniecki","year":"2007","unstructured":"Baniecki, M. L., Wirth, D. F., Clardy, J. High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Antimicrob Agents Chemother. 51 (2), 716-723 (2007).","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"e1001169","DOI":"10.1371\/journal.pmed.1001169","type":"journal-article","article-title":"The activities of current antimalarial drugs on the life cycle stages of Plasmodium: A comparative study with human and rodent parasites","volume":"9","author":"Delves","year":"2012","unstructured":"Delves, M. et al. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: A comparative study with human and rodent parasites. PLoS Med. 9 (2), e1001169 (2012).","journal-title":"PLoS Med"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"e01053","DOI":"10.1128\/AAC.01053-18","type":"journal-article","article-title":"Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds","volume":"62","author":"Calit","year":"2018","unstructured":"Calit, J. et al. Screening the pathogen box for molecules active against Plasmodium sexual stages using a new nanoluciferase-based transgenic line of P. berghei identifies transmission-blocking compounds. Antimicrob Agents Chemother. 62 (11), e01053-18 (2018).","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"e0146522","DOI":"10.1128\/aac.01465-22","type":"journal-article","article-title":"Novel transmission-blocking antimalarials identified by high-throughput screening of Plasmodium berghei Ookluc","volume":"67","author":"Calit","year":"2023","unstructured":"Calit, J. et al. Novel transmission-blocking antimalarials identified by high-throughput screening of Plasmodium berghei Ookluc. Antimicrob Agents Chemother. 67 (4), e0146522 (2023).","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3389\/fchem.2019.00773","type":"journal-article","article-title":"Integrative multi-kinase approach for the identification of potent antiplasmodial hits","volume":"7","author":"Lima","year":"2019","unstructured":"Lima, M. N. N. et al. Integrative multi-kinase approach for the identification of potent antiplasmodial hits. Front Chem. 7, 773 (2019).","journal-title":"Front Chem"},{"issue":"9","key":"ref11","doi-asserted-by":"crossref","first-page":"aac.02041","DOI":"10.1128\/AAC.02041-19","type":"journal-article","article-title":"Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium falciparum\u00c2 and\u00c2 P. vivax","volume":"64","author":"Ferreira","year":"2020","unstructured":"Ferreira, L. T. et al. Computational chemogenomics drug repositioning strategy enables the discovery of epirubicin as a new repurposed hit for Plasmodium falciparum and P. vivax. Antimicrob Agents Chemother. 64 (9), aac.02041-19 (2020).","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref12","first-page":"948","type":"journal-article","article-title":"Torin 2 derivative, NCATS-SM3710, has potent multistage antimalarial activity through inhibition of P. falciparum phosphatidylinositol 4-kinase (Pf ACS Pharmacol)","volume":"3","author":"Krishnan","year":"2020","unstructured":"Krishnan, K. et al. Torin 2 derivative, NCATS-SM3710, has potent multistage antimalarial activity through inhibition of P. falciparum phosphatidylinositol 4-kinase (Pf PI4KIII\u03b2). ACS Pharmacol.Transl Sci. 3 (5), 948-964 (2020).","journal-title":"Transl Sci"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1021\/jacsau.4c00674","type":"journal-article","article-title":"Pyrimidine azepine targets the Plasmodium bc1 complex and displays multistage antimalarial activity","volume":"4","author":"Calit","year":"2024","unstructured":"Calit, J. et al. Pyrimidine azepine targets the Plasmodium bc1 complex and displays multistage antimalarial activity. JACS Au. 4 (10), 3942-3952 (2024).","journal-title":"JACS Au"},{"issue":"20","key":"ref14","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.4155\/fmc-2018-0255","type":"journal-article","article-title":"Chalcones as a basis for computer-aided drug design: Innovative approaches to tackle malaria","volume":"11","author":"Lima","year":"2019","unstructured":"Lima, M. N. et al. Chalcones as a basis for computer-aided drug design: Innovative approaches to tackle malaria. Future Med Chem. 11 (20), 2635-2646 (2019).","journal-title":"Future Med Chem"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"e1012627","DOI":"10.1371\/journal.ppat.1012627","type":"journal-article","article-title":"A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants","volume":"20","author":"Ferreira","year":"2024","unstructured":"Ferreira, L. T. et al. A novel 4-aminoquinoline chemotype with multistage antimalarial activity and lack of cross-resistance with PfCRT and PfMDR1 mutants. PLoS Pathog. 20 (10), e1012627 (2024).","journal-title":"PLoS Pathog"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/978-1-62703-026-7_40","type":"journal-article","article-title":"Assessing transmission blockade in Plasmodium spp","volume":"923","author":"Blagborough","year":"2013","unstructured":"Blagborough, A. M. et al. Assessing transmission blockade in Plasmodium spp. Methods Mol Biol. 923, 577-600 (2013).","journal-title":"Methods Mol Biol"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"aac.02699","DOI":"10.1128\/AAC.02699-16","type":"journal-article","article-title":"Bioluminescence method for in vitro screening of Plasmodium transmission-blocking compounds","volume":"61","author":"Azevedo","year":"2017","unstructured":"Azevedo, R. et al. Bioluminescence method for in vitro screening of Plasmodium transmission-blocking compounds. Antimicrob Agents Chemother. 61 (6), aac.02699-16 (2017).","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","first-page":"119","type":"journal-article","article-title":"Characterisation of the merozoite thrombospondin related anonymous protein (MTRAP) of Plasmodium berghei as a transmission-blocking antigen","author":"Gait\u00e1n","year":"2024","unstructured":"Gait\u00e1n, X. A. et al. Characterisation of the merozoite thrombospondin related anonymous protein (MTRAP) of Plasmodium berghei as a transmission-blocking antigen. Mem Inst Oswaldo Cruz. 119, e230217 (2024).","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/68466\/ookluc-plasmodium-berghei-line-for-identifying-transmission-blocking","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:48:19Z","timestamp":1792594099000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/68466\/ookluc-plasmodium-berghei-line-for-identifying-transmission-blocking"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":18,"journal-issue":{"issue":"221","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3791\/68466","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}